L'Oreal To Buy Luxury Cosmetics Brand Aesop In $2.5 Billion Deal

By Vinícius Andrade

At L’Oreal, Aesop joins a cast of luxury brands such as Lancome and Yves Saint Laurent as the French company bets on a continued drift toward high-end cosmetics. 

L’Oreal bought Skinbetter Science, a US maker of skincare creams distributed via doctors, in recent months to boost another high-end segment it calls “active cosmetics,” with brands like as La Roche-Posay and SkinCeuticals. 

The company’s luxury unit surpassed its mass-market division two years ago to become the group’s largest, and L’Oreal expects the trend to continue. Aesop also brings a focus on clean, sustainable ingredients that can appeal to young consumers, said Bernstein analyst Bruno Monteyne.

For the Brazilian beauty firm Natura, the transaction will help cut debt and focus on turning around other businesses. Natura shares climbed 6.9% at the open in Sao Paulo, while its dollar bonds due in 2029 gained 3 cents on the dollar. L’Oreal stock rose less than 1% in Paris trading. 

Founded in 1987, Aesop has developed high-end cachet among skincare devotees with its range of pricey creams and lotions for skin, hair and body made from ingredients like geranium leaf and mandarin rind. From its first store in an underground parking lot in the Melbourne suburb of St. Kilda in 2003, it has since expanded globally including dozens of locations across New York and London. 

‘Ascending Currents’

 

“Aesop taps into all of today’s ascending currents and L’Oreal will contribute to unleash its massive growth potential, notably in China and Travel retail,” Nicolas Hieronimus, L’Oréal’s CEO, said in a statement. 

Natura acquired a majority stake in the business in 2013. Known for its natural, ethically sourced cosmetics, Sao Paulo-based Natura has faced a hard time trying to expand globally, with disruptions brought on by the pandemic and Russia’s war in Ukraine leading to cost-inflation pain. 

As the brand grew, outpacing Natura’s other ventures such as Avon and Body Shop, investors increasingly saw it as a crown jewel of the group. Aesop reported revenue of $537 million last year. It was Natura’s most profitable business, according to Lucror Analytics.

The Brazilian beauty company had been mulling a partial or total sale of Aesop as part of a broader overhaul being conducted by Fabio Barbosa, who took over as chief executive officer last year. He has sought to simplify the company’s structure and cut costs. 

Proceeds from the transaction will allow Natura to improve its capital structure and the company’s debt will become “quite manageable” after the sale, Barbosa said in a call with analysts Tuesday. Still, the firm isn’t considering any other asset sale for now, Barbosa added. 

The transaction price implies a “punchy” multiple of about 4.7 times sales, compared with about 5 times for L’Oreal and rival Estee Lauder Cos., but the growth potential appears greater, Stifel’s Fujimori said.  

In a survey with 32 local and foreign investors ahead of the transaction, Banco Bradesco BBI said most of its clients expected Natura to sell 100% of Aesop at a valuation range of between $2 billion and $2.5 billion. 

Bank of America Corp. and Morgan Stanley advised Natura on the sale while Centerview was sole adviser to L’Oreal. The deal is expected to close in the third quarter.